Argent Trust CO Edwards Lifesciences Corp Transaction History

Argent Trust CO

$2.25 Billion
Q2 2024

A detailed history of Argent Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Argent Trust CO holds 3,522 shares of EW stock, worth $230,620. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,522

Previous 3,501 0.6%

Holding current value

$230,620

Previous $334,000 2.69%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$84.3 - $94.31 $1,770 - $1,980	21 Added 0.6%	3,522 $325,000
Q1 2024 May 10, 2024	BUY	$72.54 - $95.56 $3,627 - $4,778	50 Added 1.45%	3,501 $334,000
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $26,473 - $33,359	-429 Reduced 11.06%	3,451 $263,000
Q3 2023 Nov 08, 2023	SELL	$69.28 - $93.38 $20,021 - $26,986	-289 Reduced 6.93%	3,880 $268,000
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $64,313 - $74,520	790 Added 23.38%	4,169 $393,000
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $3,564 - $4,056	48 Added 1.44%	3,379 $279,000
Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $13,933 - $17,837	-204 Reduced 5.77%	3,331 $248,000
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $149,254 - $194,409	-1,812 Reduced 33.89%	3,535 $291,000
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $5,017 - $7,439	-58 Reduced 1.07%	5,347 $509,000
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $24,368 - $30,673	-239 Reduced 4.23%	5,405 $636,000
Q3 2021 Nov 09, 2021	BUY	$102.91 - $122.75 $13,584 - $16,203	132 Added 2.39%	5,644 $639,000
Q2 2021 Aug 09, 2021	SELL	$83.84 - $104.76 $32,529 - $40,646	-388 Reduced 6.58%	5,512 $570,000
Q1 2021 May 12, 2021	SELL	$78.68 - $90.67 $4,720 - $5,440	-60 Reduced 1.01%	5,900 $494,000
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $32,618 - $41,509	-455 Reduced 7.09%	5,960 $543,000
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $131,490 - $171,120	1,957 Added 43.9%	6,415 $512,000
Q2 2020 Aug 04, 2020	BUY	$57.54 - $76.95 $175,899 - $235,236	3,057 Added 218.2%	4,458 $308,000
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $2,201 - $3,402	-42 Reduced 2.91%	1,401 $264,000
Q4 2019 Feb 11, 2020	SELL	$71.7 - $82.09 $11,472 - $13,134	-160 Reduced 9.98%	1,443 $336,000
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $29,851 - $36,583	-485 Reduced 23.23%	1,603 $353,000
Q2 2019 Aug 13, 2019	SELL	$55.74 - $64.41 $1,114 - $1,288	-20 Reduced 0.95%	2,088 $386,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $3,974 - $5,316	83 Added 4.1%	2,108 $403,000
Q4 2018 Feb 06, 2019	BUY	$46.41 - $56.94 $32,579 - $39,971	702 Added 53.06%	2,025 $310,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $22,118 - $28,086	-484 Reduced 26.78%	1,323 $227,000
Q2 2018 Apr 15, 2019	BUY	$42.45 - $51.3 $76,707 - $92,699	1,807 New	1,807 $262,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account